Skip to main content
Log in

Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of the present research was to produce a quick/slow biphasic delivery system for ibuprofen. A dual-component tablet made of a sustained release tableted core and an immediate release tableted coat was prepared by direct compression. Both the core and the coat contained a model drug (ibuprofen). The sustained release effect was achieved with a polymer (hydroxypropyl methylcellulose [HPMC] or ethylcellulose) to modulate the release of the drug. The in vitro drug release profile from these tablets showed the desired biphasic release behavior: the ibuprofen contained in the fast releasing component was dissolved within 2 minutes, whereas the drug in the core tablet was released at different times (⊂16 or >24 hours), depending on the composition of the matrix tablet. Based on the release kinetic parameters calculated, it can be concluded that the HPMC core was suitable for providing a constant and controlled release (zero order) for a long period of time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Maggi L, Machiste EO, Torre ML, Conte U. Formulation of biphasic release tablets containing slightly soluble drugs.Eur J Pharm Biopharm. 1999;48:37–42.

    Article  CAS  Google Scholar 

  2. Colombo P, Conte U, Gazzaniga A, et al. Drug release modulation by physical restrictions of matrix swelling.Int J Pharm. 1990;63:43–48.

    Article  CAS  Google Scholar 

  3. Qiu Y, Chidambaram N, Flood K. Design and evaluation of layered diffusional matrices for zero-order sustained release.J Control Release. 1998;52:123–130.

    Article  Google Scholar 

  4. Chidambaram N, Porter W, Flood K, Qui Y. Formulation and characterization of new layered diffusional matrices for zero-order sustained release.J Control Release 1998;52:149–158.

    Article  CAS  Google Scholar 

  5. Conte U, Maggi L. A flexible technology for the linear, pulsative and delayed release drugs, allowing for easy accommodation of difficult in vitro targets.J Control Release 2000;64:263–268.

    Article  CAS  Google Scholar 

  6. Uekama K, Matsubara K, Abe K, Horiuchi Y, Hirayamma F, Suzuki N. Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta-cyclodextrin: cellulose derivative combination as a modified-release drug carrier.J Pharm Sci. 1990;79:244–248.

    Article  CAS  Google Scholar 

  7. Li Y, Zhu J. Modulation of combined-release behaviours from a novel “tablets-in-capsule system.”J Control Release 2004;95:381–389.

    Article  CAS  Google Scholar 

  8. De Brabander C, Vervaet C, Görtz JP, Remon JP, Berlo JA. Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystallien wax.Int J Pharm. 2000;208:81–86.

    Article  Google Scholar 

  9. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behavior, mechanisms and optimal performance.Pharm Sci Technol Today. 2000;3:198–204.

    Article  CAS  Google Scholar 

  10. Kiil S, Dam-Johansen K. Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements.J Control Release. 2003;90:1–21.

    Article  CAS  Google Scholar 

  11. Fell JT, Newton JM. The tensile strength of lactose tablets.J Pharm Pharmacol. 1968;20:657–659.

    CAS  Google Scholar 

  12. Morre JW, Flanner HH. Mathematical comparison of dissolution profiles.Pharm Technol. 1996;20:64–74.

    Google Scholar 

  13. CDER. Center for Drug Evaluation and Research, Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage, 1997. Available at:http://www.fda.gov/cder/Guidance/1713bpl.pdf. Accessed: September 19, 2006.

  14. EMEA. European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, Note for Guidance on Quality of Modified Release Products: (A) Oral Dosage Forms; (B) Transdermal Dosage Forms; Section I (Quality), CPMP/QWP/604/96 (1999). Available at: http://www.emea.eu.int/pdfs/human/qwp/060496en.pdf. Accessed: September 19, 2006.

  15. Costa P, Sousa Lobo JM. Modelling and comparison of dissolution profiles.Eur J Pharm Sci. 2001;13:123–133.

    Article  CAS  Google Scholar 

  16. Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs.J Control Release. 1987;5:23–36.

    Article  CAS  Google Scholar 

  17. Donbrow M, Samuelov Y. Zero order drug delivery from double-layered porous films: release rate profiles from ethylcellulose, hydroxypropylcellulose and polyethylene glycol mixtures.J Pharm Pharmacol. 1980;32:463–470.

    CAS  Google Scholar 

  18. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension.J Pharm Sci. 1961;50:874–875.

    Article  CAS  Google Scholar 

  19. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of soild drugs dispersed in solid matrices.J Pharm Sci. 1963;52:1145–1149.

    Article  CAS  Google Scholar 

  20. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers.Int J Pharm. 1983;15:25–35.

    Article  CAS  Google Scholar 

  21. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers.Pharm Acta Helv. 1985;60:110–111.

    CAS  Google Scholar 

  22. Jacques CHM, Hopfenberg HB, Stannett V. Super case II transport of organic vapors in glassy polymers. In: Hopfenberger HB, ed.Permeability of Plastic Films and Coatings to Gases, Vapors, and Liquids, New York, NY: Plenum Press; 1974:73–86.

    Google Scholar 

  23. Waterman KC, Fergione MB. Press-coating of immediate release powders onto coated controlled release tablets with adhesives.J Control Release. 2003;89:387–395.

    Article  CAS  Google Scholar 

  24. Johansson B, Wikberg M, Ek R, Alderborn G. Compression behaviour and compactability of microcrystalline cellulose pellets in relationship to their pore structure and mechanical properties.Int. J. Pharm. 1995;117:57–73.

    Article  CAS  Google Scholar 

  25. Johansson B, Nicklasson F, Alderborn G. Effect of pellet size on degree of deformation and densification during compression and on compactability of microcrystalline cellulose pellets.Int J Pharm. 1998;163:35–48.

    Article  CAS  Google Scholar 

  26. Johansson B, Alderborn G. The effect of shape and porosity on the compression behaviour and tablet forming ability of granular materials formed from microcrystalline cellulose.Eur J Pharm Biopharm. 2001;52:347–357.

    Article  CAS  Google Scholar 

  27. Tunón A, Borjesson E, Frenning G, Alderborn G. Drug release from reservoir pellet compacted with some excipients of different physical properties.Eur J Pharm Sci. 2003;20:469–479.

    Article  Google Scholar 

  28. Lopes CM, Sousa Lobo JM, Pinto JF, Costa P. Compressed mini-tablets as a biphasic delivery system.Int J Pharm. 2006;323:93–100.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carla Martins Lopes.

Additional information

Published: September 21, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lopes, C.M., Sousa Lobo, J.M., Pinto, J.F. et al. Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen. AAPS PharmSciTech 8, 76 (2007). https://doi.org/10.1208/pt0803076

Download citation

  • Received:

  • Revised:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt0803076

Keywords

Navigation